ARDX
Price
$5.14
Change
-$0.06 (-1.15%)
Updated
Aug 7 closing price
Capitalization
1.24B
83 days until earnings call
VCYT
Price
$27.68
Change
+$3.71 (+15.48%)
Updated
Aug 7 closing price
Capitalization
1.66B
95 days until earnings call
Interact to see
Advertisement

ARDX vs VCYT

Header iconARDX vs VCYT Comparison
Open Charts ARDX vs VCYTBanner chart's image
Ardelyx
Price$5.14
Change-$0.06 (-1.15%)
Volume$4.28M
Capitalization1.24B
Veracyte
Price$27.68
Change+$3.71 (+15.48%)
Volume$2.56M
Capitalization1.66B
ARDX vs VCYT Comparison Chart in %
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. VCYT commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and VCYT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ARDX: $5.14 vs. VCYT: $27.68)
Brand notoriety: ARDX and VCYT are both not notable
ARDX represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARDX: 91% vs. VCYT: 178%
Market capitalization -- ARDX: $1.24B vs. VCYT: $1.66B
ARDX [@Biotechnology] is valued at $1.24B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 6 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • ARDX’s TA Score: 6 bullish, 4 bearish.
  • VCYT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а +21.23% price change this week, while VCYT (@Medical Specialties) price change was +15.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.63%. For the same industry, the average monthly price growth was -1.59%, and the average quarterly price growth was -3.41%.

Reported Earning Dates

ARDX is expected to report earnings on Oct 30, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+0.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than ARDX($1.24B). ARDX YTD gains are higher at: 1.381 vs. VCYT (-30.101). ARDX has higher annual earnings (EBITDA): -28.23M vs. VCYT (-49.41M). VCYT (216M) and ARDX (214M) have equal amount of cash in the bank . VCYT has less debt than ARDX: VCYT (12.6M) vs ARDX (155M). ARDX (362M) and VCYT (361M) have equivalent revenues.
ARDXVCYTARDX / VCYT
Capitalization1.24B1.66B74%
EBITDA-28.23M-49.41M57%
Gain YTD1.381-30.101-5%
P/E RatioN/AN/A-
Revenue362M361M100%
Total Cash214M216M99%
Total Debt155M12.6M1,230%
FUNDAMENTALS RATINGS
ARDX vs VCYT: Fundamental Ratings
ARDX
VCYT
OUTLOOK RATING
1..100
8353
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9788
PRICE GROWTH RATING
1..100
4365
P/E GROWTH RATING
1..100
4783
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (80) in the Biotechnology industry is in the same range as ARDX (98). This means that VCYT’s stock grew similarly to ARDX’s over the last 12 months.

VCYT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARDX (100). This means that VCYT’s stock grew similarly to ARDX’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as ARDX (97). This means that VCYT’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's Price Growth Rating (43) in the Biotechnology industry is in the same range as VCYT (65). This means that ARDX’s stock grew similarly to VCYT’s over the last 12 months.

ARDX's P/E Growth Rating (47) in the Biotechnology industry is somewhat better than the same rating for VCYT (83). This means that ARDX’s stock grew somewhat faster than VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTSIX37.84N/A
N/A
FullerThaler Behvrl S-M Cor Eq Instl
HSAFX9.86N/A
N/A
Hussman Strategic Allocation
EQNSX22.60N/A
N/A
MFS Equity Income R2
LGLOX57.58N/A
N/A
Lord Abbett Growth Leaders F3
QCLVX34.05N/A
N/A
Federated Hermes MDT Large Cap Value C

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-1.15%
VCYT - ARDX
45%
Loosely correlated
+15.48%
PCVX - ARDX
35%
Loosely correlated
-9.06%
RNAC - ARDX
35%
Loosely correlated
-6.56%
CGEN - ARDX
33%
Poorly correlated
-1.37%
MAIA - ARDX
31%
Poorly correlated
-2.63%
More